RhumbLine Advisers
SBC

RhumbLine Advisers’s SBC Medical Group SBC Stock Holding History

RhumbLine Advisers’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.9K Buy
6,447
+1,133
+21% +$4.73K ﹤0.01% 3683
2025
Q4 		$22.9K Sell
5,314
-1,164
-18% -$4.44K ﹤0.01% 3744
2025
Q3 		$28.1K Sell
6,478
-3,167
-33% -$14.3K ﹤0.01% 3740
2025
Q2 		$44.7K Buy
+9,645
New +$38.1K ﹤0.01% 3686

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers's SBC Position: Q1 2026 in Review

RhumbLine Advisers increased its SBC Medical Group (SBC) stake by 21% in Q1 2026, buying an estimated $4.73K and bringing the position to 6,447 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

RhumbLine Advisers first reported a position in SBC in Q2 2025 and has held it in 4 quarters since. The position peaked at $44.7K in Q2 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • RhumbLine Advisers held 6,447 shares of SBC Medical Group worth $26.9K as of Q1 2026.
  • RhumbLine Advisers bought 1,133 SBC Medical Group shares in Q1 2026, an estimated $4.73K.
  • SBC Medical Group made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3683 holding.
  • RhumbLine Advisers first reported a position in SBC Medical Group in Q2 2025 and has held it in 4 quarters since.
  • RhumbLine Advisers's SBC Medical Group position peaked at $44.7K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.